You are here: Industry Insights > vaccine

News List

A vaccine against chronic inflammatory diseases worldpharmanews
December 17, 2019
Chronic inflammatory bowel diseases, such as Crohn's Disease and ulcerative colitis, are linked to abnormalities of the gut microbiota in humans and in animals.
Pfizer to debut podcast series around vaccines fiercepharma
December 12, 2019
Pfizer’s latest podcast is a documentary-style dive into vaccines. The eight-part?series, called “The Antigen,” launches in mid-December and tackles the scientific ...
Technique to manufacture virus-like particle polio vaccines developed europeanpharmaceuticalreview
December 10, 2019
University of Leeds researchers have discovered a method to produce polio vaccines made from virus-like particles, which is being trialled on a manufacturing platform.
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland En-CPhI.CN
November 25, 2019
WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development ...
Thermally stable chikungunya vaccine developed by researchers europeanpharmaceuticalreview
September 27, 2019
Researchers have developed a chikungunya vaccine that can be stored at warm temperatures and manufactured quickly, which has been validated in animal models.
Experimental Genital Herpes Vaccine Shows Promise in Mice drugs
September 27, 2019
An experimental vaccine against genital herpes is extremely effective in mice, offering hope of human protection against an incurable sexually transmitted disease ...
FDA approves vaccine for smallpox and monkeypox europeanpharmaceuticalreview
September 26, 2019
The US Food and Drug Administration (FDA) has announced the approval of Jynneos, a smallpox and monkeypox vaccine for patients 18 years of age or older at high risk of the condition.
DRC announces plans to use second Ebola vaccine europeanpharmaceuticalreview
September 24, 2019
Health authorities in the Democratic Republic of Congo are planning to use a second vaccine to treat the Ebola virus.
Dengue virus becoming resistant to vaccines and therapeutics due to mutations in specific protein worldpharmanews
September 23, 2019
Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII) ...
FDA accepts Biologics License Application for V920 Ebola vaccine europeanpharmaceuticalreview
September 20, 2019
A Biologics License Application and priority review has been approved by the FDA for an investigational Ebola vaccine.